Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study

OBJECTIVE: To determine whether use of dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists are associated with an increased risk of cholangiocarcinoma in adults with type 2 diabetes. DESIGN: Population based cohort study. SETTING: General practices contrib...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrahami, Devin, Douros, Antonios, Yin, Hui, Yu, Oriana HY, Faillie, Jean-Luc, Montastruc, François, Platt, Robert W, Bouganim, Nathaniel, Azoulay, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278586/
https://www.ncbi.nlm.nih.gov/pubmed/30518618
http://dx.doi.org/10.1136/bmj.k4880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278586/
https://www.ncbi.nlm.nih.gov/pubmed/30518618
http://dx.doi.org/10.1136/bmj.k4880

Ejemplares similares